Equity in Vaccine Trials for Higher Weight People? A Rapid Review of Weight-Related Inclusion and Exclusion Criteria for COVID-19 Clinical Trials

Higher weight status, defined as body mass index (BMI) ≥ 30 kg/m(2), is frequently described as a risk factor for severity and susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (known as COVID-19). Therefore, study groups in COVID-19 vaccine trials should be repr...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Jessica, Sutherland, Juliet, Bucknall, Danielle, O’Hara, Lily, Heywood, Anita, Hobbs, Matthew, Ballantyne, Angela, Gray, Lesley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708246/
https://www.ncbi.nlm.nih.gov/pubmed/34960212
http://dx.doi.org/10.3390/vaccines9121466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708246/
https://www.ncbi.nlm.nih.gov/pubmed/34960212
http://dx.doi.org/10.3390/vaccines9121466

Ejemplares similares